Fortune 500 Pharmaceutical Company
A Fortune 500 Pharmaceutical company known for using science-based innovation to contrive breakthrough treatments, turned to ktMINE to assist in uncovering research on expected and reasonable royalty rates for technologies post-patent expiry.